Electroconvulsive therapy (ECT) is used to treat patients with major depression and other affective disorders. The main benefit of ECT is rapid clinical improvement compared with oral antidepressants. The mortality rate is low, about 0.03% per patient 1,2 , or 0.0045% of treatments 3, 4 . The majority of medical complications that occur are cardiovascular in origin 5 , and these account for the main cause of death during ECT 4 . Events such as cardiac rupture, cardiogenic shock, ventricular arrhythmias and asystole have been reported 1 . Whilst generally low, the incidence of these complications is higher in patients with preexisting cardiac disease or arrhythmias 6 . The case described highlights this point.
CASE HISTORY
A 78-year-old man was readmitted with profound catatonic depression associated with psychomotor retardation and severe anorexia, 19 days after discharge following elective coronary artery bypass graft (CABG) surgery. His past medical history included ischaemic heart disease with two previous myocardial infarctions, depression (at least one episode previously requiring ECT), hypercholesterolaemia, hiatus hernia, an episode of angina-associated palpitations and syncope 12 months previously, and an admission 12 years previously with symptomatic tachyarrhythmias diagnosed as ventricular tachycardia (VT) that spontaneously converted to rapid AF.
Following the CABG surgery (with four grafts) the patient experienced a series of complications. In the cardiothoracic ICU immediately postoperatively, an episode of VT occurred that responded to amiodarone. Day 3 postoperatively the patient experienced left arm numbness and weakness that was diagnosed on computed tomography as a small right parietal cerebrovascular accident (CVA). Echocardiography performed the following day showed an apical thrombus in the left ventricle, and anticoagulation was commenced with IV heparin and oral warfarin. On the fifth postoperative day, rapid atrial fibrillation occurred and verapamil was added to the therapeutic regimen to facilitate rate control. By day 8 postoperatively the patient was stable and well enough to be transferred to a private hospital for further convalescence. His CVA symptoms by this time had completely resolved and medications on transfer consisted of warfarin, digoxin, lisinopril, simvastatin, quinine, frusemide, potassium (slow release preparation), verapamil and ranitidine.
At the time of his readmission for severe depression, the patient remained in atrial fibrillation, but the ventricular rate was well controlled. A psychiatric review was obtained. In view of the patient's weakened physical condition from the associated anorexia, and his previous good response to this mode of therapy, a course of ECT was recommended. Consent was obtained. Serum electrolytes were within normal limits and the international normalized ratio (INR) was 3.6. The patient received a total of six treatments commencing the following day. These were delivered using a Thymatron™ DG, giving 512mC of charge in a square-wave pulse with a 0.5ms waveform plateau. All stimuli were bilateral to facilitate rapidity of clinical improvement, with the exception of the first, which was a right unilateral treatment. Stimulus dose titration was not performed. The patient's first ECT was relatively uneventful with a brief period of bradycardia followed by tachycardia and hypertension in association with the clonic phase of the seizure. These changes were brief and self-limiting, and are regarded as a normal response to ECT (see below). The treatment was otherwise only complicated by multifocal ventricular ectopics (VE) immediately postprocedure without haemodynamic compromise. A second treatment performed three days later was uncomplicated. The patient's third treatment was similar to the first and again associated with multifocal VEs. In the recovery period, nursing staff reported a tachyarrhythmia associated with the patient appearing pale and sweaty, and a small drop in blood pressure. The arrhythmia lasted approximately five minutes, but not long enough to be documented formally. A 12 lead ECG showed atrial fibrillation and (R) bundle branch block with multifocal VEs, unchanged from admission.
Following this episode, the patient was recommenced on amiodarone and verapamil was ceased. The medical team decided to attempt cardioversion prior to the next ECT, two days later. Unconsciousness was induced with propofol 100mg and cardioversion attempted unsuccessfully at 100J and 200J. A third attempt at 360J proved successful, but the patient remained in sinus rhythm for less than 30 seconds before reverting to atrial fibrillation. At this point the cardioversion was abandoned, the patient given a further 50mg of propofol and suxamethonium 50mg and bilateral ECT delivered. This resulted in a clinical seizure of only 17 seconds (EEG recording also 17 seconds), at the conclusion of which the patient was found to be in normal sinus rhythm. He was transferred to the recovery room where he remained well and in sinus rhythm.
The fifth ECT was performed five days later after an earlier scheduled treatment was cancelled as the patient was not fasted. The patient was still in sinus rhythm which was maintained throughout an uneventful procedure. In the recovery room, an episode of supraventricular tachycardia (SVT) occurred with a rate of approximately 120 beats/min and witnessed by the anaesthetist responsible for the patient. This was associated with the patient appearing clinically unwell, pale and sweaty, but without significant haemodynamic compromise or ST-segment changes. The arrhythmia was treated conservatively and spontaneously resolved after about 15 minutes, with the patient reverting again to sinus rhythm.
Two days later the patient was anaesthetized, but the ECT procedure was abandoned due to a fault in the Thymatron™ which failed to deliver any current. The patient remained in sinus rhythm and made an uneventful recovery. The final (sixth) ECT was delivered uneventfully three days later. After a gradual improvement in the patient's mental state and resolution of his depression over the course of ECT, he was well enough to be discharged home the same afternoon. Venlafaxine was commenced as an oral antidepressant for discharge.
DISCUSSION
Arrhythmias and myocardial ischaemia comprise the majority of cardiovascular complications from ECT, and occur in the range of 8 to 80%. The higher incidence occurs in those patients with pre-existing cardiac disease 3, [6] [7] [8] . Most of the arrhythmias tend to be benign and self-limiting with a reported incidence of 10 to 40% 3, 8 , or up to 72% for sinus tachycardia in one report 9 . The incidence of vagally mediated arrhythmias (predominantly sinus bradycardia) is reported to be 30 to 70% 3 . In patients without significant cardiac abnormalities, transient benign arrhythmias occur infrequently. Ventricular arrhythmias may be potentially lethal but appear to be rare. The incidence of ventricular tachycardia (VT) in association with ECT is unknown and reports in the literature are scarce. Reports of atrial fibrillation as a result of ECT are also infrequent.
It is well recognised that the combination of depression and ischaemic heart disease increases the incidence of cardiac events, including arrhythmias, and puts the patient at increased risk of cardiacassociated morbidity and mortality. The mechanism for this association remains unclear. It is established that patients with major depression have altered autonomic nervous system activity, as indicated by higher resting heart rates and reduced heart rate variability when compared to healthy (nondepressed) controls [10] [11] [12] [13] [14] . Elevated plasma and urinary catecholamines (particularly noradrenaline) have also been found in patients with major depression 10, 11 . Whether this autonomic imbalance is predominantly due to an increase in sympathetic activity or a decrease in parasympathetic activity is unclear 10, 11, 15, 16 . An increase in sympathetic tone has been associated with a lowered threshold for ventricular arrhythmias. Changes in resting heart rate and heart rate variability due to an autonomic imbalance also put patients with depressive disorders at increased risk for arrhythmias (particularly ventricular) and sudden cardiac death 10, 11 . ECT imposes a physiological stress associated with significant autonomic and cardiovascular disturbance. When an electrically induced cerebral seizure occurs, the hypothalamus, pituitary, thyroid and adrenal glands are affected. There is increased cerebral blood flow and oxygen consumption, as well as raised intracranial, intraocular and intragastric pressures 3, 4, 8 . Stimulation of the hypothalamus causes cardiovascular changes due to first parasympathetic then sympathetic stimulation. With seizure onset a tonic phase of about 10 seconds duration occurs, associated with ECG changes attributable to vagal stimulation such as sinus bradycardia or even transient asystole. Other signs of increased vagal tone such as hypotension and increased salivation may also occur 3 . Following this brief phase, a more prolonged period of clonic muscle activity occurs associated with intense sympathetic stimulation producing tachycardia, hypertension and an increased incidence of arrhythmias 3, 4, 8 . The clonic phase of the seizure is associated with a dose-dependent and marked rise in circulating catecholamines released from the adrenal medulla and, to a lesser extent, from sympathetic nerve endings. The catecholamine levels rise to 15 times baseline for adrenaline, and three times baseline for noradrenaline, with peaks at one to three minutes after the end of the seizure 3, 4, 8, 17 . These rises in catecholamine levels predominantly account for the dose-dependent increase in systolic and diastolic blood pressure 17 , and contribute to the tachycardia seen with ECT.
High levels of circulating catecholamines predispose the myocardium to ventricular arrhythmias 3, 6 . In addition hypertension, tachycardia and increased cardiac output 4 seen in response to ECT increase myocardial work and oxygen consumption. Increased skeletal muscle tone and activity also increase total oxygen consumption. In patients with preexisting ischaemic heart disease, myocardial oxygen demand may exceed supply and result in focal or generalized areas of ischaemia which may develop hyperirritability and initiate arrhythmias 3, 4, 6, 8, 18, 19 . Inhomogeneity of ventricular repolarization due to direct autonomic stimulation, in the absence of ischaemia, may also contribute to arrhythmias during ECT 1 . In this case the patient had a relatively benign and common arrhythmia that was initially made worse by electroconvulsive therapy (in the form of tachyarrhythmias and clinical signs of sympathetic stimulation). The incidence reported in the literature of atrial fibrillation in association with ECT is surprisingly low, and the incidence of AF reverting to sinus rhythm after the procedure appears to be even lower. A series has been reported 20 of six patients with AF undergoing ECT, in whom four reverted (either briefly or persistently) to normal sinus rhythm after the treatment. There has been one case reported of elective cardioversion being attempted prior to ECT. In this case elective cardioversion of AF was unsuccessful after multiple attempts. A subsequent ECT was uneventful, the patient remaining in AF. A subsequent cardioversion was successful, and further ECTs were uncomplicated with maintenance of sinus rhythm 21 . The case presented here is the first of failed cardioversion, followed by reversion to sinus rhythm in association with ECT. The reasons underlying cardioversion in response to ECT are unclear. Autonomic effects are likely to have played a major role, since this patient previously exhibited signs of ECT-induced autonomic stimulation in association with changes in cardiac rhythm. Changes in autonomic tone may also modify the electrophysiologic efficacy of antiarrhythmic medication 22 , and this patient was taking both amiodarone and digoxin at the time of treatment. It is known that repeated attempts at cardioversion at the same level of energy delivered have a greater chance of success because of lowered thoracic impedance with subsequent shocks 23 . It is unlikely that this had an effect in this case, since the ECT current was of a lower energy and delivered to a different location. It is my opinion that the failed elective cardioversion in this case was coincidental, and is unlikely to have had an influence on the subsequent conversion of AF to normal sinus rhythm associated with the ECT.
Whether patients in AF should be anticoagulated prior to undergoing ECT has been raised previously in the literature 20, 22 . It is common practice to anticoagulate patients in AF prior to elective cardioversion, to reduce the risks of embolization. Despite the fact that patients with depression have enhanced platelet reactivity and aggregation [10] [11] [12] 24 , possibly putting them at increased risk from thromboembolic phenomena, cerebrovascular events in the setting of ECT are extremely rare 25 . Anticoagulation of patients in AF prior to ECT has been advocated 20 . This would appear to be not without risk, although ECT treatment during continuous anticoagulation therapy has been described in at least 12 patients without serious complication [26] [27] [28] . The question of whether ECT increases the risk of intracerebral haemorrhage in anticoagulated patients has not been extensively studied, and remains controversial. Similarly, the low incidence of adverse events from embolization in patients receiving ECT makes a convincing evidence based plan difficult to formulate. Echocardiography prior to ECT to detect intracardiac thrombus in patients with AF could assist clinical decision making.
